Anisha B. Patel

2.0k total citations · 1 hit paper
88 papers, 1.1k citations indexed

About

Anisha B. Patel is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Anisha B. Patel has authored 88 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 26 papers in Molecular Biology and 26 papers in Dermatology. Recurrent topics in Anisha B. Patel's work include Cancer Immunotherapy and Biomarkers (29 papers), Melanoma and MAPK Pathways (18 papers) and Colorectal Cancer Treatments and Studies (16 papers). Anisha B. Patel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (29 papers), Melanoma and MAPK Pathways (18 papers) and Colorectal Cancer Treatments and Studies (16 papers). Anisha B. Patel collaborates with scholars based in United States, United Kingdom and Spain. Anisha B. Patel's co-authors include Mario E. Lacouture, Omar Pacha, Jonathan L. Curry, Jonathan E. Rosenberg, Peter H. O’Donnell, Michael T. Tetzlaff, Doina Ivan, Phyu P. Aung, Matt Thompson and Stephen J. Incavo and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Anisha B. Patel

78 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin

2022 87 citations Mario E. Lacouture, Anisha B. Patel et al. The Oncologist profile →

Peers

Countries citing papers authored by Anisha B. Patel

Since Specialization

Citations

This map shows the geographic impact of Anisha B. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anisha B. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anisha B. Patel more than expected).

Fields of papers citing papers by Anisha B. Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anisha B. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anisha B. Patel. The network helps show where Anisha B. Patel may publish in the future.

Co-authorship network of co-authors of Anisha B. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Anisha B. Patel. A scholar is included among the top collaborators of Anisha B. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anisha B. Patel. Anisha B. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune Checkpoint Inhibitor (Durvalumab) Induced Pneumonitis 2025 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), (unknown), Arindam Chatterjee, (unknown), S.M. Hutson, (unknown), Anisha B. Patel, (unknown), (unknown), (unknown), (unknown), (unknown), Muhammad H. Zaman	0
2	Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors 2025 ·Journal for ImmunoTherapy of Cancer ·Omar Pacha, Anisha B. Patel, Jonathan L. Curry, Cara Haymaker, (unknown), Dzifa Y. Duose, Ken Chen, Joud Hajjar, Aung Naing	1
3	Assessing the context within academic health institutions toward improving equity-based, community and patient-engaged research 2024 ·Journal of Clinical and Translational Science ·Prajakta Adsul, Shannon Sanchez‐Youngman, Elizabeth Dickson, (unknown), (unknown), Michael Muhammad, Katherine J. Briant, Bridgette Hempstead, Jason A. Mendoza, Lisa G. Rosas, Anisha B. Patel, Patricia Rodríguez Espinosa, Tabia Henry Akintobi, (unknown), Lori Carter‐Edwards, Nina Wallerstein	4
4	Resolution of metastatic cutaneous Crohn's disease with upadacitinib monotherapy 2024 ·JAAD Case Reports ·(unknown), (unknown), Anisha B. Patel, Stephen K. Tyring	0
5	Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1 2024 ·Journal of Neuro-Oncology ·(unknown), (unknown), (unknown), (unknown), Zsila Sadighi, Anisha B. Patel	1
6	Altmetric Analysis of Dermatology Manuscript Dissemination During the COVID-19 Era: Cross-Sectional Study 2023 ·JMIR Dermatology ·(unknown), (unknown), (unknown), Anisha B. Patel	0
7	Immune checkpoint inhibitor-induced cutaneous toxicities: a review of histopathologic and clinical features 2023 ·Human Pathology ·(unknown), (unknown), Anisha B. Patel	1
8	Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis 2023 ·BioMed Research International ·John P. Vanden Heuvel, Shuling Zhou, Anisha B. Patel, (unknown), (unknown), (unknown)	1
9	Immune checkpoint inhibitor-induced vitiligo in cancer patients: characterization and management 2023 ·Archives of Dermatological Research ·Jonathan W. Lo, (unknown), (unknown), Anisha B. Patel	2
10	Acneiform eruptions with combination targeted cancer therapy in colorectal cancer patients 2022 ·Supportive Care in Cancer ·(unknown), (unknown), Rohit Gupta, Christine M. Parseghian, Anisha B. Patel	3
11	Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin breakdown → 2022 ·The Oncologist ·Mario E. Lacouture, Anisha B. Patel, Jonathan E. Rosenberg, Peter H. O’Donnell	87
12	Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer 2022 ·Cancer Prevention Research ·(unknown), Anisha B. Patel, J. Jack Lee, Diane D. Liu, Mike Hernández, Miguel Muzzio, Alejandro Contreras, (unknown), (unknown), Diane Weber, Lana A. Vornik, Seema A. Khan, Eileen Dimond, Brandy M. Heckman‐Stoddard, Marjorie Perloff, Powel H. Brown	4
13	Systemic Treatment of Cutaneous Adverse Events after Immune Checkpoint Inhibitor Therapy: A Review 2021 ·Dermatitis ·(unknown), (unknown), (unknown), Anisha B. Patel	10
14	Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit 2021 ·Cancer ·Anisha B. Patel, (unknown), (unknown), Rodabe N. Amaria, Susan Y. Chon, Adi Diab, Isabella C. Glitza Oliva, Auris Huen, (unknown), Kelly C. Nelson, Omar Pacha, Sapna P. Patel, Ronald P. Rapini, Hussein A. Tawbi, Michael K. Wong, Jennifer L. McQuade, Michael A. Davies, Lauren E. Haydu	13
15	Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy 2021 ·Clinical Lung Cancer ·(unknown), Anisha B. Patel, Mehmet Altan	9
16	Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy 2021 ·Cancer Discovery ·Mario E. Lacouture, Zev A. Wainberg, Anisha B. Patel, Milan J. Anadkat, Salomon M. Stemmer, Einat Shacham‐Shmueli, Egmidio Medina, (unknown), (unknown), Antoni Ribas	16
17	Junctional melanocytic hyperplasia overlying benign fibrous papule: An under‐recognized variant of a common lesion 2020 ·Journal of Cutaneous Pathology ·(unknown), Anisha B. Patel	1
18	Application of least absolute shrinkage and selection operator logistic regression for the histopathological comparison of chondrodermatitis nodularis helicis and hyperplastic actinic keratosis 2020 ·Journal of Cutaneous Pathology ·Saisindhu Narala, (unknown), (unknown), Anisha B. Patel	11
19	Characterization of Cutaneous Adverse Events Associated With PI3K Inhibitors in 11 Patients 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Omar Pacha, Anisha B. Patel	3
20	IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy 2019 ·Cancer Immunology Research ·Daniel H. Johnson, Anisha B. Patel, Marc Uemura, Van Anh Trinh, Natalie Jackson, Chrystia M. Zobniw, Michael T. Tetzlaff, Patrick Hwu, Jonathan L. Curry, Adi Diab	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact